IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CANCARINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.687
EU - Europa 7.623
AS - Asia 6.069
SA - Sud America 1.226
AF - Africa 140
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 27.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.504
CN - Cina 2.202
SG - Singapore 2.006
IT - Italia 1.885
PL - Polonia 1.551
UA - Ucraina 1.464
BR - Brasile 1.019
DE - Germania 772
HK - Hong Kong 676
FI - Finlandia 414
FR - Francia 414
VN - Vietnam 362
GB - Regno Unito 333
RU - Federazione Russa 260
TR - Turchia 223
IE - Irlanda 222
IN - India 181
BD - Bangladesh 124
CA - Canada 86
AR - Argentina 67
NL - Olanda 61
SE - Svezia 59
MX - Messico 56
BE - Belgio 51
ID - Indonesia 47
IQ - Iraq 43
EC - Ecuador 41
ZA - Sudafrica 35
NG - Nigeria 34
JP - Giappone 28
VE - Venezuela 26
PK - Pakistan 25
AT - Austria 24
CZ - Repubblica Ceca 22
ES - Italia 22
CO - Colombia 20
IR - Iran 20
PY - Paraguay 19
UZ - Uzbekistan 19
MA - Marocco 17
SA - Arabia Saudita 16
AU - Australia 15
EG - Egitto 15
CL - Cile 13
EU - Europa 13
JO - Giordania 13
LT - Lituania 13
PE - Perù 10
RO - Romania 10
TN - Tunisia 10
JM - Giamaica 9
KZ - Kazakistan 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
HN - Honduras 8
OM - Oman 8
KE - Kenya 7
DZ - Algeria 6
HR - Croazia 6
NP - Nepal 6
UY - Uruguay 6
BG - Bulgaria 5
CH - Svizzera 5
ET - Etiopia 5
IL - Israele 5
KR - Corea 5
LB - Libano 5
LV - Lettonia 5
PH - Filippine 5
BO - Bolivia 4
PA - Panama 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
KG - Kirghizistan 3
KW - Kuwait 3
MY - Malesia 3
NO - Norvegia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
GR - Grecia 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
Totale 27.757
Salva come PNG Salva come JPEG
Città #
Warsaw 1.548
Fairfield 1.359
Woodbridge 1.152
Jacksonville 1.048
Singapore 1.047
Ashburn 1.009
Houston 787
Hong Kong 673
Ann Arbor 618
Chandler 593
Cambridge 591
Seattle 505
Wilmington 463
The Dalles 437
Beijing 418
Princeton 418
Nanjing 370
San Jose 348
New York 283
Dublin 219
Dallas 217
Milan 214
Helsinki 212
Istanbul 187
Lauterbourg 184
Los Angeles 160
Nanchang 137
Ho Chi Minh City 131
Munich 125
Rome 115
Dearborn 113
Des Moines 107
Buffalo 105
Brescia 102
Hebei 82
Moscow 80
Shenyang 79
São Paulo 78
Jiaxing 77
Changsha 75
San Diego 73
Tianjin 72
Hanoi 65
Jinan 53
Shanghai 53
Verona 49
Redondo Beach 48
Brussels 47
Council Bluffs 46
Dong Ket 44
Chicago 42
Santa Clara 41
Kunming 40
London 40
Naples 37
San Francisco 37
Boardman 36
Orem 35
Abuja 34
Chennai 34
Toronto 34
Hangzhou 32
Florence 31
Turin 31
Rio de Janeiro 30
Lanzhou 28
Atlanta 27
Belo Horizonte 26
Frankfurt am Main 26
Tokyo 25
Ningbo 24
Stockholm 24
Brooklyn 23
Lancaster 23
Mexico City 23
San Mateo 23
Turku 23
Nuremberg 22
Bologna 21
Zhengzhou 21
Augusta 20
Brno 20
Jakarta 20
Bergamo 19
Curitiba 19
Falls Church 19
Guangzhou 19
Palermo 19
Genoa 18
Monmouth Junction 18
Denver 17
Phoenix 17
Amsterdam 16
Baghdad 16
Bari 16
Leawood 16
Montreal 16
Mumbai 16
Taizhou 16
Tashkent 16
Totale 18.262
Salva come PNG Salva come JPEG
Nome #
Mancata ripopolazione dei B linfociti periferici dopo un singolo ciclo di Rituximab in pazienti con vasculite ANCA associata (AAV) all'esordio mai esposti in precedenza a farmaci immunosoppressivi 1.229
Vasculiti ANCA associate (AAV) con presenza di indicatore sierico di attivazione della via alterna del complemento: valutazione degli outcomes. 484
Incremental peritoneal dialysis: a 10 year single-centre experience 325
PRIMA E DOPO IL TRAPIANTO DI RENE: EMODIALISI VS. DIALISI PERITONEALE. 300
SOVRAPPESO POST-DIALITICO E INFIAMMAZIONE CRONICA: UNA ASSOCIAZIONE PERICOLOSA. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI. 272
Low-protein diets for chronic kidney disease patients: The Italian experience 263
SCLEROSI PERITONEALE INCAPSULANTE IN DIALISI PERITONEALE: UNA “BELVA” IN GABBIA? 257
EFFETTO DELLA TERAPIA CON INIBITORI DEL SISTEMA RENINA-ANGIOTENSINA SUI LIVELLI SIERICI DI POTASSIO NEI PAZIENTI EMODIALIZZATI. UNO STUDIO OSSERVAZIONALE 256
CORREZIONE DELL’IPOVITAMINOSI D [25(OH)D3] NEL PAZIENTE DIALIZZATO. EFFETTI SUL METABOLISMO CALCIO-FOSFORICO 255
Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity. 252
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 250
Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients. 249
END-DIALYSIS OVERWEIGHT AND CHRONIC INFLAMMATION. A DANGEROUS CONNECTION 246
L’ENTITÀ’ DEL SOVRAPPESO POST-DIALITICO E’ ASSOCIATO CON LA MORTALITA’ TOTALE E CARDIOVASCOLARE NEI PAZIENTI EMODIALIZZATI. STUDIO PROSPETTICO OSSERVAZIONALE DI 36 MESI 234
Varianti della malattia da anticorpi anti-GBM (mAbGBM): malattia renale da anticorpi anti-GBM in assenza di anticorpi circolanti 232
RUOLO DELLA COMPONENTE CONVETTIVA SULLE VARIAZIONI SIERICHE DI BETA 2 MICROGLOBULINA (?B2M), PROTEINA C REATTIVA (?HSCRP), E FABBISOGNO DI EPO (?EPO) IN PAZIENTI EMODIALIZZATI TRATTATI CON HDF ON-LINE POST DILUZIONALE. 227
PERITONITE DA MYCOBACTERIUM ABSCESSUS IN CAPD: CASE REPORT. 227
IL RUOLO DEL GRADIENTE DIALITICO DEL SODIO SULL’AUMENTO DEI VALORI DI PRESSIONE ARTERIOSA DURANTE LA DIALISI. UNO STUDIO OSSERVAZIONALE 207
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 192
Pregnancy outcomes after kidney graft in Italy: Are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 189
A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report. 188
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 185
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients 185
The MEST score provides earlier risk prediction in lgA nephropathy 184
Vascular access in older patients: an Italian survey. 182
Assessment of Vascular Structural and Functional Alterations In Apolipoprotein A-i Amyloidosis (leu75pro) 178
A more tubulocentric view of diabetic kidney disease 178
Magnitude of End-Dialysis Overweight is Associated with All-Cause and Cardiovascular Mortality: A 3-Year Prospective Study. 176
Differing dialysis treatment strategies and outcome. 175
Achievement of NKF/K-DOQI recommended target values for bone and mineral metabolism in incident hemodialysis patients: Results of the FARO-2 cohort 174
Nutritional treatment of advanced CKD: twenty consensus statements 172
A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD 171
A six year comparison of patient and technique survivals in CAPD and HD 171
CAVECTOMIA PER INFILTRAZIONE NEOPLASTICA DA NEOPLASIA RENALE PARENCHIMALE DESTRA 171
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 169
A peritoneal dialysis solution prepared from a three-compartment bag: biological and clinical effects. 168
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 168
Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. 165
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. 164
Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. 163
Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration 163
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 157
Monoclonal Lambda Free Liht Chains:biochemical behavoiur and pathogenetic classification 157
Effectiveness of kidney transplantation in HIV-infected recipients under combination antiretroviral therapy: a single-cohort experience (Brescia, Northern Italy) 156
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 155
TRANSUDATIVE PLEURAL EFFUSION DUE TO PLEUROPERITONEAL COMMUNICATION IN PERITONEAL DIALYSIS PATIENTS WITH POLYCISTIC KIDNEY DISEASE 155
A competing risks model with a time dependent variable: the effects of hypertension onset in the comorbidities history in type 2 diabetes 154
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort 152
PERITONITE IN DP: CONFRONTO TRA METODICHE 151
Which vascular access for chronic hemodialysis in uremic elderly patients? 146
Assessment of calcemic status in dialyzed uraemic patients. 145
MALNUTRITION INFLAMMATION SCORE AND RISK OF HOSPITALISATION AND MORTALITY IN PERITONEAL DIALYSIS PATIENTS. 144
Clinical policies on the management of chronic kidney disease patients in Italy. 142
Adeguatezza del trattamento dialitico: aspetti pratici. 141
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 141
Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. 141
How to manage elderly patients with chronic renal failure: conservative management versus dialysis 141
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro). A case-control study 140
Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: a longitudinal study. 139
Myocardial ultrasound tissue characterization in patients with chronic renal failure 139
Carotid Artery Structural Alterations In Patients With Apolipoprotein A-i Amyloidosis (leu75pro) 139
Effect of VDRA on survival in incident hemodialysis patients: Results of the FARO-2 observational study 139
Experience with cyclosporine. 138
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy. 138
A prospective evaluation of endothelial dysfunction in systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results 138
A prospective evaluation of endothelial dysfunction in Systemic Lupus Erythematosus patients without previous cardiovascular events: preliminary results. 138
Porphyria and pseudo-porphyria in hemodialyzed patients. 137
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity 137
Dialysis initiation: what's the rush? 136
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. 136
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. 135
Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral((R)) plus Rapamune((R)): four-yr results of a randomized monocenter study. 135
PD or not PD? That is the question. 133
Steroid-free immunosuppression regime reduces both long-term cardiovascular morbidity and patient mortality in renal transplant recipients 133
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience 132
Diethylene Glycol Poisoning From Transcutaneous Absorption 131
Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. 131
PERITONITE IN DP: DIABETICI vs. NON-DIABETICI 131
Interrelationships between blood pressure, blood gases and plasma acetate concentrations during conventional hemodialysis. 130
Transplantation outcome in patients PD and HD 130
Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. 130
Role of dialysis sodium gradient on intradialytic hypertension: an observational study. 130
Efficacy and safety of a very-low-protein diet when postponing dialysis in the elderly: a prospective randomized multicenter controlled study. 129
Plasma catecholamine response to postural stimulation in normotensive and dialysis hypotension-prone uremic patients. 128
Strategy for preventing peritoneal dialysis failure. 128
Management of hypertension in chronic renal failure. 127
Porphyria cutanea tarda in a haemodialysed patient. 126
'Y' connector system for prevention of peritonitis in CAPD: a controlled study. 126
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 125
Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. 124
Renal transplantation and peritoneal dialysis 124
Retroperitoneal fibrosis at the onset of ANCA associated vasculitis: The risk of a delay in the diagnosis of vasculitis 124
Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy. 124
Drugs in the elderly with chronic kidney disease: beware of potentially inappropriate medications. 124
Evidence for an independent role of metabolic acidosis on nutritional status in haemodialysis patients. 123
Correction of metabolic acidosis on serum albumin and protein catabolism in hemodialysis patients. 122
Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study. 122
Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation. 122
Ciclosporina (Cs) nei trapianti di rene: è utile il monitoraggio dei through-levels (BTL)? 122
Re-treatment with rituximab in ANCA-associated vasculitis only in the presence of clinical relapse: A single centre experience 122
Totale 17.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.692 114 298 45 106 42 88 98 146 80 210 139 326
2022/20231.820 239 22 28 185 167 476 24 202 268 24 86 99
2023/20241.448 92 35 68 109 61 226 69 85 358 34 44 267
2024/20253.634 50 78 44 363 486 291 368 150 431 264 670 439
2025/20266.451 563 864 678 952 528 455 896 238 407 510 267 93
Totale 28.059